S. Prabhu et al., A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species, INT J PHARM, 217(1-2), 2001, pp. 71-78
The presence of bound and unbound zinc in the crystal matrix of protein sus
pensions helps physically stabilize the crystal and limits the dissolution
of the drug. In case of zinc insulin suspensions, dissolution can be promot
ed by complexation of zinc with an ionic species for which the zinc has a g
reater affinity, these complexing ions having either formulation and/or phy
siological relevance. The purpose of this work was to use ligand-complexed
formulations of insulin suspensions to gain an understanding of these produ
cts' dissolution performance and to establish a fundamental understanding o
f the rate-limiting steps in zinc insulin dissolution. Our group has sugges
ted that the critical factors to zinc insulin dissolution are: (1) chemical
complexation (zinc with ionic species); and (2) drug transport (insulin di
ffusion and solubility). Dissolution studies conducted using different ioni
c species (acetate, phosphate, citrate and EDTA) in a spin-filter device de
monstrated a rank order correlation for different sources of zinc insulin;
it was observed that human zinc insulin dissolved faster than bovine insuli
n, these differences attributed to their binding properties and the respect
ive affinities to the various ionic species used. Also, as the amount of cr
ystallinity increased in a formulation, a rank order increase in dissolutio
n times was observed. The project also identified a sensitive and reproduci
ble dissolution testing methodology. Overall, this study demonstrated that:
(I) the complexation rate-limiting step was more significant in the dissol
ution of zinc insulin than the diffusion rate-limiting step; and (2) that d
issolution kinetics depended primarily on the source and solid state differ
ences and the binding affinities of the zinc insulin. (C) 2001 Elsevier Sci
ence B.V. All rights reserved.